Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CASI Pharmaceuticals (CASI) Current Leases (2021 - 2024)

Historic Current Leases for Pharmaceuticals (CASI) over the last 4 years, with Q4 2024 value amounting to $1.2 million.

  • Pharmaceuticals' Current Leases rose 6771.98% to $1.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.2 million, marking a year-over-year increase of 6771.98%. This contributed to the annual value of $1.2 million for FY2024, which is 6771.98% up from last year.
  • Pharmaceuticals' Current Leases amounted to $1.2 million in Q4 2024, which was up 6771.98% from $728000.0 recorded in Q4 2023.
  • Pharmaceuticals' Current Leases' 5-year high stood at $1.2 million during Q4 2024, with a 5-year trough of $728000.0 in Q4 2023.
  • Moreover, its 4-year median value for Current Leases was $964500.0 (2021), whereas its average is $969500.0.
  • Its Current Leases has fluctuated over the past 5 years, first tumbled by 1819.04% in 2022, then skyrocketed by 6771.98% in 2024.
  • Quarter analysis of 4 years shows Pharmaceuticals' Current Leases stood at $1.1 million in 2021, then decreased by 18.19% to $868000.0 in 2022, then fell by 16.13% to $728000.0 in 2023, then skyrocketed by 67.72% to $1.2 million in 2024.
  • Its last three reported values are $1.2 million in Q4 2024, $728000.0 for Q4 2023, and $868000.0 during Q4 2022.